logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
G

Gary M. Clark

Baylor College of Medicine

87H指数
314论文数
5.6W被引数
收录论文 31
发表时间
logo
Trench Foot: Waging a War Against Pediatric Small Fiber Neuropathy
errNEUROLOGY
IF8.5
err2023-04-25
err0
PREAI
errLevine, Jesse; Newell, Meagan; Domingue, Alyssa; Clark, Gary
err分享
err收藏
A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment
errJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
err2009-10-23
err91
errOAAI
errTaube, Sheila E.; Clark, Gary M.; Dancey, Janet E.; McShane, Lisa M.; Sigman, Caroline C.; Gutman, Steven I.
err分享
err收藏
Prognostic factors versus predictive factors: Examples from a clinical trial of erlotinib
errMOLECULAR ONCOLOGY
IF4.5
err2007-12-08
err122
errOAAI
errClark, Gary M.
err分享
err收藏
REporting recommendations for tumor MARKer prognostic studies (REMARK)肿瘤标志物预后研究报告建议 (备注)
errBREAST CANCER RESEARCH AND TREATMENT
IF3
err2006-08-24
err667
PREAI
errMcShane, Lisa M.; Altman, Douglas G.; Sauerbrei, Willi; Taube, Sheila E.; Gion, Massimo; Clark, Gary M.
err分享
err收藏
Smoking history and epidermal growth factor receptor expression as predictors of survival benefit from erlotinib for patients with non-small-cell lung cancer in the National Cancer Institute of Canada Clinical Trials Group study BR.21
errCLINICAL LUNG CANCER
IF3.3
err2006-05-01
err151
PREAI
errClark, Gary M.; Zborowski, Denni M.; Santabarbara, Pedro; Ding, Keyue; Whitehead, Marlo; Seymour, Lesley; Shepherd, Frances A.
err分享
err收藏
Morphologic and immunophenotypic markers as surrogate endpoints of tamoxifen effect for prevention of breast cancer
errBREAST CANCER RESEARCH AND TREATMENT
IF3
err2005-11-02
err12
PREAI
errMohsin, SK; Allred, DC; Osborne, CK; Cruz, A; Otto, P; Chew, H; Clark, GM; Elledge, RM
err分享
err收藏
Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies过度表达核转移相关1 (MTA1) 蛋白的乳腺肿瘤具有高复发风险，但对全身治疗的反应增强
errBREAST CANCER RESEARCH AND TREATMENT
IF3
err2005-10-22
err55
PREAI
errMartin, MD; Hilsenbeck, SG; Mohsin, SK; Hopp, TA; Clark, GM; Osborne, CK; Allred, DC; O'Connell, P
err分享
err收藏
Reporting recommendations for tumor marker prognostic studies (REMARK)
errJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
err2005-08-17
err1.3K
errOAAI
errMcShane, LM; Altman, DG; Sauerbrei, W; Taube, SE; Gion, M; Clark, GM
err分享
err收藏
REporting recommendations for tumour MARKer prognostic studies (REMARK)肿瘤标志物预后研究报告建议 (备注)
errBRITISH JOURNAL OF CANCER
IF6.8
err2005-08-02
err1.1K
errOAAI
errMcShane, LM; Altman, DG; Sauerbrei, W; Taube, SE; Gion, M; Clark, GM
err分享
err收藏
REporting recommendations for tumour MARKer prognostic studies (REMARK)肿瘤标志物预后研究报告建议 (备注)
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2005-08-01
err229
PREAI
errMcShane, LM; Altman, DG; Sauerbrei, W; Taube, SE; Gion, M; Clark, GM
err分享
err收藏
Erlotinib in previously treated non-small-cell lung cancer厄洛替尼治疗非小细胞肺癌
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2005-07-14
err5.0K
errOAAI
errShepherd, FA; Pereira, JR; Ciuleanu, T; Tan, EH; Hirsh, V; Thongprasert, S; Campos, D; Maoleekoonpiroj, S; Smylie, M; Martins, R; van Kooten, M; Dediu, M; Findlay, B; Tu, DS; Johnston, D; Bezjak, A; Clark, G; Santabárbara, P; Seymour, L
err分享
err收藏
Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study (vol 17, pg 1554, 2004)
errMODERN PATHOLOGY
IF5.5
err2005-03-01
err2
errOAAI
errMohsin, SK; Weiss, H; Havighurst, T; Clark, GM; Berardo, M; Roanh, LD; To, TV; Qian, Z; Love, RR; Allred, DC
err分享
err收藏
Hazard rates of recurrence following diagnosis of primary breast cancer
errBREAST CANCER RESEARCH AND TREATMENT
IF3
err2005-01-01
err79
PREAI
errJatoi, I; Tsimelzon, A; Weiss, H; Clark, GM; Hilsenbeck, SG
err分享
err收藏
Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study
errMODERN PATHOLOGY
IF5.5
err2004-12-01
err241
errOAAI
errMohsin, SK; Weiss, H; Havighurst, T; Clark, GM; Berardo, M; Roarth, L; To, TV; Zho, Q; Love, RR; Allred, DC
err分享
err收藏
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome乳腺浸润性小叶癌: 肿瘤特征和临床结果
errBREAST CANCER RESEARCH
IF5.6
err2004-02-17
err693
errOAAI
errArpino, G; Bardou, VJ; Clark, GM; Elledge, RM
err分享
err收藏
Consensus Statement: Expedition Inspiration Fund for Breast Cancer Research Meeting 2002
errBREAST CANCER RESEARCH AND TREATMENT
IF3
err2003-03-01
err0
errOAAI
errBenz, C; Clark, G; Conzen, S; Dorn, R; Fuqua, S; Gralow, J; Greene, G; Heimann, R; Hellman, S; Lippman, M; Rosen, N; Weiner, L
err分享
err收藏
Maspin expression in invasive breast cancer: association with other prognostic factors浸润性乳腺癌中Maspin的表达: 与其他预后因素的关联
errJOURNAL OF PATHOLOGY
IF5.2
err2003-02-10
err135
PREAI
errMohsin, SK; Zhang, M; Clark, GM; Allred, DC
err分享
err收藏
Idoxifene versus tamoxifen: a randomized comparison in postmenopausal. patients with metastatic breast cancer
errANNALS OF ONCOLOGY
IF65.4
err2003-02-01
err29
errOAAI
errArpino, G; Krishnan, MN; Dinesh, CD; Bardou, VJ; Clark, GM; Elledge, RM
err分享
err收藏
Survival of patients with metastatic breast carcinoma - Importance of prognostic markers of the primary tumor
errCANCER
IF5.1
err2003-01-17
err244
errOAAI
errChang, J; Clark, GM; Allred, DC; Mohsin, S; Chamness, G; Elledge, RM
err分享
err收藏
Adenoid cystic carcinoma of the breast - Molecular markers, treatment, and clinical outcome
errCANCER
IF5.1
err2002-04-15
err152
errOAAI
errArpino, G; Clark, GM; Mohsin, S; Bardou, VJ; Elledge, RM
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
D
Douglas G. Altman
H 指数: 257 · 论文数: 962
F
Frances A. Shepherd
H 指数: 127 · 论文数: 1.1K
N
Neal Rosen
H 指数: 126 · 论文数: 996
E
Eleftherios P. Diamandis
H 指数: 117 · 论文数: 1.5K
C
Christopher C. Benz
H 指数: 114 · 论文数: 440
查看更多